- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06176183
A Comparative Prospective Study of the Arthroscopic Meniscal Repair Methods
A Comparative Prospective Study of Meniscal Repair Methods in Young Patients With Traumatic Meniscal Tears.
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Vilnius, Lithuania, LT-08661
- Recruiting
- Vilnius University Hospital Santaros Klinikos
-
Contact:
- Viktorija Brogaite Martinkeniene, MD
- Phone Number: 37069805546
- Email: viktorija.brogaite@santa.lt
-
Vilnius, Lithuania, LT-03101
- Recruiting
- Vilnius University, Medical faculty
-
Contact:
- Viktorija Brogaite Martinkeniene, MD
- Phone Number: 37069805546
- Email: viktorija.brogaite@mf.vu.lt
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Individuals who provide consent to participate in the study, including patients and their care providers. The inclusion criteria for this study are as follows: being under the age of 19, having a traumatic isolated full-thickness meniscal tear longer than 1cm that has been confirmed by both preoperative MRI and arthroscopy, and not having undergone any previous surgery on the affected knee.
Exclusion Criteria:
- This investigation excludes patients with developmental disabilities who are unable to read or interpret in their native language.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Cohort I of patients
Individuals who undergo the conventional arthroscopic meniscus repair procedure
|
A traditional two-portal arthroscopic approach is utilized. The meniscal edges are examined using a probe, and any meniscal tears that are not stable are evaluated for potential repair. For meniscus repair, sutures have been made using the "all-inside" or "outside-inside" and "inside-outside" techniques. If the procedure involving the addition of a fibrin clot is being carried out, a volume of approximately 60 milliliters of blood is taken and thereafter transferred into a basin. An assistant is able to stir the blood using a glass syringe for approximately fifteen minutes to ensure sufficient coagulation surrounding the syringe. After a sufficient clot has developed at the end of the syringe, a grasper is used to insert the clot through the anterolateral arthroscopy portal. The meniscal sutures are intentionally loosened to accommodate the clot in the meniscus, ensuring optimal contact with the lesion. Subsequently, the sutures are fastened and knotted.
Other Names:
|
|
Other: Cohort II of patients
Patients who receive the supplementary fibrin clot augmentation during the arthroscopic meniscus repair operation.
|
A traditional two-portal arthroscopic approach is utilized. The meniscal edges are examined using a probe, and any meniscal tears that are not stable are evaluated for potential repair. For meniscus repair, sutures have been made using the "all-inside" or "outside-inside" and "inside-outside" techniques. If the procedure involving the addition of a fibrin clot is being carried out, a volume of approximately 60 milliliters of blood is taken and thereafter transferred into a basin. An assistant is able to stir the blood using a glass syringe for approximately fifteen minutes to ensure sufficient coagulation surrounding the syringe. After a sufficient clot has developed at the end of the syringe, a grasper is used to insert the clot through the anterolateral arthroscopy portal. The meniscal sutures are intentionally loosened to accommodate the clot in the meniscus, ensuring optimal contact with the lesion. Subsequently, the sutures are fastened and knotted.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pediatric International Documentation Committee Subjective (Pedi-IKDC) Knee Form.
Time Frame: before treatment, after 12 months and 24 months following treatment
|
Pedi-IKDC is used to measure knee-related symptoms, function, and sports activity among children.
The questionnaire consists of 13 items, each of which is scored using one of three rating systems: a range of 0 to 10 for items 2, 3, 12, and 13, a range of 0 to 4 for items 1, 4, 5, 6, 9, and 10, and a range of 0 to 1 for items 7 and 8.
The 11th item consists of nine subquestions, each of which can be scored from 0 to 4. The overall score value is calculated by adding only the responses to 12 items and dividing the total by 92 (the highest number of points attainable).
The score runs from 0 (worst case scenario) to 100 (best case scenario).
The Pedi-IKDC has been proven to be a valid, trustworthy, and responsive questionnaire in a paediatric population with varied knee disorders, especially ligament and meniscal injuries, joint instability, and other disorders
|
before treatment, after 12 months and 24 months following treatment
|
|
Lysholm knee scale
Time Frame: before treatment, after 12 months and 24 months following treatment
|
Lysholm knee scoring scale has been proven to be suitable for a variety of knee pathologies and also for the adolescent population.
The scale comprises eight items.
Higher values of the score indicate better functioning of the knee.
(range from 0 to 100).
|
before treatment, after 12 months and 24 months following treatment
|
|
Health-related paediatric quality of life (PedsQL)
Time Frame: before treatment, after 12 months and 24 months following treatment
|
PedsQL is a generic score, which estimates the quality of life of paediatric patients.
The questionnaire consists of four domains with 23 questions: the general physical functioning, emotional, social, and functioning at school domains
|
before treatment, after 12 months and 24 months following treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
magnetic resonance imaging (MRI scan) of the knee
Time Frame: before treatment, after 12 months and 24 months following treatment
|
1.5T MRI system.
Four main diagnostic sequences were analyzed, including sagittal proton density fast spin echo (PD FS-Sag), sagittal T2-weighted fast spin echo (T2W-Sag), coronal proton density fast spin echo with fat saturation (PD FS-Cor), and coronal T2-weighted fast spin echo with fat saturation (T2W-Cor).
Signal changes on MRI are graded using Stoller and Crues' 3-stage classification.
Grade 0 was defined as a normal meniscus; the meniscus demonstrates low signal intensity in the images.
Grade 1 is described as an intrameniscal signal with irregular margins that do not connect or communicate with an articular surface.
Grade 2 is defined as a linear signal that does not abut or communicate with an articular surface.
A linear or complex signal intensity that abuttes or communicates with an articular surface is classified as Grade 3. In summary, grade 3 is deemed unhealed, grade 2 as partially healed, and grade 1 as fully healed due to MRI assessment.
|
before treatment, after 12 months and 24 months following treatment
|
|
Clinical evaluation at 12 and 24 months postoperatively. The clinical assessment involves evaluating of pain, swelling and estimating and comparing the range of motion of the knee with the contralateral side.
Time Frame: 12 and 24 months postoperatively.
|
All patients are evaluated
|
12 and 24 months postoperatively.
|
|
Revision rates (secondary arthroscopies)
Time Frame: 12 and 24 month following primary surgery
|
secondary arthroscopies (revision) at 12 and 24 month following primary surgery
|
12 and 24 month following primary surgery
|
Collaborators and Investigators
Sponsor
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2021/5-1353-825
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Meniscus Tear Caused by a Traumatic Event
-
Austin V StoneThe Cleveland Clinic; Duke University; University of California, San FranciscoRecruitingPost-traumatic Osteoarthritis | ACL Injury | Meniscus TearUnited States
-
University of Colorado, DenverRecruitingInflammation Caused by the Placement of a Temporary Anchorage DeviceUnited States
-
DePuy InternationalTerminatedRheumatoid Arthritis | Cuff Tear Arthropathy | Osteoarthritis With Cuff Deficiency | Post Traumatic Injury to Shoulder | Revision Surgery of a Failed Anatomic Shoulder ProsthesisFrance, Belgium, Germany
-
IVI SevillaUniversity of Seville, SpainRecruitingEstablish the Amount of CENPV Protein in Human Oocytes As a Diagnostic Tool Against Damage Caused by Ageing or by the Procedure of Vitrification of Oocytes | Advance Maternal Age | Vitrification and ThawingSpain
-
SeqirusCompletedInfluenza Caused by the Novel Influenza A (H1N1) VirusAustralia
-
SeqirusCompletedInfluenza Caused by the Novel Influenza A (H1N1) VirusAustralia
-
University of OxfordCompletedEnteric Fever Caused by Salmonella Enterica Serovar Paratyphi AUnited Kingdom
-
Finnish Institute for Health and WelfareCompletedInfluenza Caused by the Novel A(H1N1)v Influenza VirusFinland
-
Atrial Fibrillation NetworkCompletedAtrial Fibrillation | Assessment of Serious Advers Events | Thromboembolic and Bleeding Complications | Complications of Antiarrhythmic Drugs or Invasive Procedures | Assessment by a Critical Event CommitteeGermany
-
Istanbul University - Cerrahpasa (IUC)Not yet recruitingUnconsciousness | Traumatic Brain Injury | Subarachnoid Hemorrhage | Coma | Infratentorial Neoplasms | Epilepsy, Temporal Lobe | Assessment, Self | Intensive Care Neurological Disorder | Arnold Chiari Malformation | Cerebrovascular Event | Postoperative Intracranial Hematoma | Postoperative Intracranial Haemorrhage and other conditionsTurkey
Clinical Trials on Arthroscopic meniscus repair
-
University of Southern DenmarkOdense University Hospital; Lillebaelt Hospital, Kolding and Vejle, DenmarkCompletedKnee Osteoarthritis | Meniscus InjuryDenmark
-
Ain Shams UniversityActive, not recruiting
-
eMKa MED Medical CenterWroclaw Medical UniversityRecruitingMeniscus; Detachment, Current Injury | Detachment | Medial Mensical Tear | Medial Meniscus Knee InjuryPoland
-
Sue Barber-WestinWithdrawnCartilage DiseaseUnited States
-
Mayo ClinicEnrolling by invitationMeniscus TearUnited States
-
Peking University Third HospitalCompletedMeniscus Injury | The ACL RuptureChina
-
Cairo UniversityCompleted
-
Cairo UniversityCompletedPartial Thickness Articular-Side Rotator Cuff TearsEgypt
-
Pei-Yuan Lee, MDAeon Biotechnology CorporationUnknown
-
Samsung Medical CenterUnknownSubscapularis Tendon Tear | Arthroscopic Repair | Arthroscopic DebridementKorea, Republic of